VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,651 | -10.6% | 210 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,323 | -6.9% | 210 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,794 | +12.9% | 210 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,019 | +20.4% | 210 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -28.6% | 210 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000 | +16.7% | 210 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -57.1% | 210 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $14,000 | -26.3% | 420 | -26.4% | 0.00% | -33.3% |
| Q1 2021 | $19,000 | -9.5% | 571 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $21,000 | +31.2% | 571 | +36.0% | 0.00% | +50.0% |
| Q3 2020 | $16,000 | +100.0% | 420 | +100.0% | 0.00% | +100.0% |
| Q2 2020 | $8,000 | +60.0% | 210 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -16.7% | 210 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | 0.0% | 210 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | +20.0% | 210 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $5,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $25,094,000 | 16.41% |
| Windmill Hill Asset Management Ltd | 844,600 | $28,700,000 | 15.26% |
| Hollow Brook Wealth Management LLC | 671,454 | $22,816,000 | 14.18% |
| New Harbor Financial Group, LLC | 1,167,112 | $39,658,000 | 13.37% |
| Grand Central Investment Group | 423,252 | $14,382,000 | 12.82% |
| New Harbor Financial Group, LLC | 1,101,300 | $37,422,000 | 12.62% |
| Cadence Wealth Management LLC | 432,124 | $14,684,000 | 12.40% |
| Bienville Capital Management, LLC | 4,007,300 | $136,168,000 | 11.31% |
| ONE PLUS ONE WEALTH MANAGEMENT, LLC | 460,504 | $15,648,000 | 10.79% |
| Plaisance Capital LLC | 608,000 | $20,660,000 | 10.29% |